Vimarsana
Biggest News Aggregation in the World

Page 21 - Class Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Class Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Class Program Today - Breaking & Trending Today

Report to Congress on Navy SSN(X) Next-Generation Attack Submarine - Vimarsana News

Report to Congress on Navy SSN(X) Next-Generation Attack Submarine

The following is the Dec 9, 2021 Congressional Research Service In Focus report, Navy Next-Generation Attack Submarine (SSN[X]) Program: Background and Issues for Congress. From the report The Navy wants to begin procuring a new class of nuclear-powered attack submarine (SSN), called the Next-Generation Attack Submarine or SSN(X), in FY2031. The SSN(X) would be the […]

Source: usni.org
Report to Congress on Navy SSN(X) Next-Generation Attack Submarine - Vimarsana News

Report to Congress on Navy SSN(X) Next-Generation Attack Submarine

The following is the Aug 10, 2021 Congressional Research Service In Focus report, Navy Next-Generation Attack Submarine (SSN[X]) Program: Background and Issues for Congress. From the report Introduction and Issue for Congress The Navy wants to begin procuring a new class of nuclear-powered attack submarine (SSN), called the Next-Generation Attack Submarine or SSN(X), in FY2031. […]

Source: usni.org
Report to Congress on Navy SSN(X) Next-Generation Attack Submarine - Vimarsana News

Report to Congress on Navy SSN(X) Next-Generation Attack Submarine

The following is the June 1, 2021 Congressional Research Service In Focus report, Navy Next-Generation Attack Submarine (SSN[X]) Program: Background and Issues for Congress. From the report The Navy wants to begin procuring a new class of nuclear-powered attack submarine (SSN), called the Next-Generation Attack Submarine or SSN(X), in FY2031. The SSN(X) would be the […]

Source: usni.org
AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH - Vimarsana News

AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH

Bemarituzumab is a Strong Strategic Fit With Amgen’s Innovative Oncology Portfolio Amgen to Host Investor Call at 10:30 a.m. EST THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 4, 2021 – Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, today announced an agreement under which Amgen will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of approximately $1.9 billion. This acquisition adds Five Prime’s innovative ...

Detailed text transcripts for TV channel - FOXNEWS - 20111019:08:09:00 - Vimarsana News

Detailed text transcripts for TV channel - FOXNEWS - 20111019:08:09:00

>> it's incoon consequenceial to me after the health and human being services secretary coming out friday and saying we are not going to implement it. >> somebody in the cbo woke up to say you know what the republicans said about this a year-and-a-half ago was true. so they killed the program. now today they say it's not dead. >> they say the class program could not meet the legal requirement it not ask to the deficit. >> last friday, somebody in obama administration said we've got a nightmare on our hands and we can't let it get started. it will blow a whole in the budget. >> liberal supports...